Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Andrea V. Margulis"'
Autor:
Pamela K. Foreman, Andrea V. Margulis, Kimberly Alexander, Renee Shediac, Brian Calingaert, Abenah Harding, Manel Pladevall-Vila, Sarah Landis
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-18 (2021)
Abstract Background Phenylalanine hydroxylase (PAH) deficiency is an autosomal recessive disorder that results in elevated concentrations of phenylalanine (Phe) in the blood. If left untreated, the accumulation of Phe can result in profound neurocogn
Externí odkaz:
https://doaj.org/article/3e44081e8a374ed68ac64f9082d1ee16
Autor:
Annete Njue, Carolyn Coyne, Andrea V. Margulis, Dai Wang, Morgan A. Marks, Kevin Russell, Rituparna Das, Anushua Sinha
Publikováno v:
Viruses, Vol 13, Iss 1, p 20 (2020)
Human cytomegalovirus (CMV) is a major cause of nonhereditary adverse birth outcomes, including hearing and visual loss, neurologic deficits, and intrauterine growth retardation (IUGR), and may contribute to outcomes such as stillbirth and preterm de
Externí odkaz:
https://doaj.org/article/4cdb290f9d0e4b33ba6eb5df334e07f6
Publikováno v:
Pharmacoepidemiology and Drug Safety.
We aimed to describe the distribution of gestational age at birth (GAB) to inform the estimation of GAB when clinical or obstetric estimates are not available for perinatal epidemiologic research. We estimated GAB (median, mode, mean, standard deviat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e37fd6ff9ad638c8c556db1425b21f5
https://doi.org/10.1101/2022.10.19.22281268
https://doi.org/10.1101/2022.10.19.22281268
Autor:
Andrea V Margulis, Marie Linder, Alejandro Arana, Anton Pottegård, Ina Anveden Berglind, Christine L Bui, Nina Sahlertz Kristiansen, Shahram Bahmanyar, Lisa J McQuay, Willem Jan Atsma, Kwame Appenteng, Milbhor D'Silva, Susana Perez-Gutthann, Jesper Hallas
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0204456 (2018)
PURPOSE:To describe the use of antimuscarinic drugs to treat overactive bladder (OAB) in Denmark, Sweden, and the United Kingdom (UK). METHODS:We identified new users of darifenacin, fesoterodine, oxybutynin, solifenacin, tolterodine, and trospium ag
Externí odkaz:
https://doaj.org/article/5c7ff1827f6b40b49627f2619eafb006
Autor:
Andrea V. Margulis, Kwame Appenteng, Stefan de Vogel, Susana Perez-Gutthann, Lisa J. McQuay, Alejandro Arana, Cristina Varas-Lorenzo, Billy Franks, Maria Reynolds, Alicia Gilsenan, Christine L. Bui, Cristina Rebordosa
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose Strategies to identify and validate acute myocardial infarction (AMI) and stroke in primary‐care electronic records may impact effect measures, but to an unknown extent. Additionally, the validity of cardiovascular risk factors that could a
Publikováno v:
Pharmacoepidemiology and drug safetyREFERENCES. 31(1)
PURPOSE Publications provide important information for clinicians, researchers, and patients. Key methodological elements must be reported for maximum transparency. We identified key methodological elements necessary for fully understanding perinatal
Autor:
Cheryl Enger, Libby Horter, Nina Sahlertz Kristiansen, Stefan de Vogel, Kelesitse Phiri, Brandon T. Suehs, Jesper Hallas, Alejandro Arana, Marie Linder, Ingvild Odsbu, Yihua Xu, Andrea V. Margulis, Kwame Appenteng, John D. Seeger, Morten Olesen, Veena Hoffman, Susana Perez-Gutthann
Publikováno v:
Hoffman, V, Hallas, J, Linder, M, Margulis, A, Suehs, B T, Arana, A, Phiri, K, Enger, C, Horter, L, Odsbu, I, Olesen, M, Perez-Gutthann, S, Xu, Y, Kristiansen, N S, Appenteng, K, de Vogel, S, Seeger, J D & the mirabegron PMR-PASS study group 2021, ' Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder : Findings from a Non-Interventional, Multinational, Cohort Study ', Drug Safety, vol. 44, no. 8, pp. 899-915 . https://doi.org/10.1007/s40264-021-01095-7
Drug Safety
Drug Safety
Introduction During clinical trials, mirabegron, a β3-adrenoreceptor agonist, was associated with increased vital signs vs placebo in patients with overactive bladder. Objective The purpose of this study was to compare incidence rates of adverse car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606ed98949016a3becf28423411ba054
https://findresearcher.sdu.dk:8443/ws/files/191412893/Hoffman2021_Article_CardiovascularRiskInUsersOfMir.pdf
https://findresearcher.sdu.dk:8443/ws/files/191412893/Hoffman2021_Article_CardiovascularRiskInUsersOfMir.pdf
Autor:
Alejandro Aranaa, Andrea V. Margulis
Publikováno v:
Epidemiology (Cambridge, Mass.). 32(5)
PurposePublications are an important information source for clinicians, researchers, and patients. Key methodological elements must be reported for maximum transparency. We identified key methodological elements necessary for fully understanding phar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08946aa430673599e8fef1351b16edb4
https://doi.org/10.1101/2021.05.04.21256602
https://doi.org/10.1101/2021.05.04.21256602